The pharmacokinetics profile of active pharmaceutical ingredients (APIs) in the solid pharmaceutical dosage forms is largely dependent on the solid-state characteristics of the chemicals to understand the physicochemical properties by particle size, size distribution, surface area, solubility, stability, porosity, thermal properties, etc. The formation of salts, solvates, and polymorphs are the conventional strategies for altering the solid characteristics of pharmaceutical compounds, but they have their own limitations. Cocrystallization approach was established as an alternative method for tuning the solubility, permeability, and processability of APIs by introducing another compatible molecule/s into the crystal structure without affecting its therapeutic efficacy to successfully develop the formulation with the desired pharmacokinetic profile. In the present review, we have grossly focused on cocrystallization, particularly at different stages of development, from design to production. Furthermore, we have also discussed regulatory guidelines for pharmaceutical industries and challenges associated with the design, development and production of pharmaceutical cocrystals with commercially available cocrystal-based products.
Design and development of new materials and their hybrids are key to addressing current energy issues. Thanks to their tunable textural and physiochemical properties, metal–organic frameworks (MOFs) show great potential toward gas sorption, catalysis, sensing, and electrochemical energy applications. Nevertheless, practical applications of MOFs have been hampered because of their limited electrical conductivity, micropore size, and poor stability. However, smart integration of zero-dimensional quantum dots (QDs) into an MOF template, where the host structure offers suitable interactions for enhancing the stability and synergic properties, may be a solution. The objective of this review is to summarize recent advances in the field of QD@MOFs, highlighting fresh approaches to synthesis strategies and progress made in their application to optoelectronic devices, sensing, biomedical, catalysis, and energy storage. The current challenges and future directions of QDs@MOFs hybrids toward advancing energy and environmental applications are also addressed. We anticipate that this review will inspire researchers to develop novel MOF hybrids for energy, optoelectronics, and biomedical applications.
A convenient and practical synthetic approach for α-ketoamides has been developed under mild conditions. The facile synthesis of α-ketoamides has been accomplished using aryl vinyl azides and secondary amines at room temperature. The inexpensive and readily available iodine and TBHP easily promoted the oxidative amidation process to afford diketoamide derivatives in high yields. This method involves the synthesis of ketoamide compounds via sequential C–O and C–N bond formation. Moreover, metal-free and aerobic conditions and wide substrate scope are the notable advantages of this protocol.
A metal-free and efficient oxidative C(sp)–H functionalization of alkynes has been developed for the synthesis of 1,2-diketones. A composite of tert-butyl nitrite and ascorbic acid effectively promoted the oxidative addition of a phenyl radical generated from aniline to terminal alkynes producing α-diketones. The one-pot strategy involves 2-methyltetrahydrofuran (2-MeTHF) as a useful alternative reaction medium for oxidative diketonation. Furthermore, the protocol provides a novel route to symmetrical and unsymmetrical substituted 1,2-diketones from easily accessible reactants. Notably, environmentally benign reagents, greener and renewable solvents, a broad range of substrates, large-scale synthesis, lower E-factors, practical applications, radical pathways and mild conditions are the promising features of the present method.
28 November 2021 in Journal of Heterocyclic Chemistry